FDA records re­quest lands Chi­nese API man­u­fac­tur­er on blocked im­port list

The FDA this week post­ed an un­ti­tled let­ter sent Oct. 17 to Chi­na-based ac­tive phar­ma­ceu­ti­cal in­gre­di­ent (API) man­u­fac­tur­er Shan­dong Boyuan Phar­ma­ceu­ti­cal Co., whose ex­ports to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER